Atlas Trials

A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)

Clinical trial NCT05181241 · COMPLETED

Trial details

NCT number
NCT05181241
Sponsor
PharmaDiall Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2017-01-25
Primary completion
2017-12-25
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.